CymaBay Therapeutics, Inc.
Treatment of intrahepatic cholestatic diseases
Last updated:
Abstract:
Treatment of intrahepatic cholestatic diseases by therapy with MBX-8025 or an MBX-8025 salt.
Status:
Application
Type:
Utility
Filling date:
3 Oct 2020
Issue date:
28 Jan 2021